All AbMole products are for research use only, cannot be used for human consumption.

Candesartan (Atacand) is an angiotensin II receptor antagonist with an IC50 of 15 ug/kg. It reduced the risk of developing hypertension by nearly two-thirds during this period. In the last two years of the study, all participants were switched to placebo. By the end of the study, candesartan had significantly reduced the risk of hypertension, by more than 15%.
| Cell Experiment | |
|---|---|
| Cell lines | KU-19-19 cells |
| Preparation method | Seeding KU-19-19 cells at a cell density of 2 ×104 per well in 96-well plates and allowed to grow overnight. Then treating the cells with various concentrations of Candesartan for various periods of time. Cell viability is determined by the Alamar Blue assay to examine the cytotoxicity and antiproliferative effect of candesartan. Determining the absorbance value of each well in a microplate reade |
| Concentrations | 10 μM |
| Incubation time | 48 hours |
| Animal Experiment | |
|---|---|
| Animal models | Mouse KU-19-19 xenograft model |
| Formulation | Saline |
| Dosages | 10 mg/kg |
| Administration | Gavage |
| Molecular Weight | 440.45 |
| Formula | C24H20N6O3 |
| CAS Number | 139481-59-7 |
| Form | Solid |
| Solubility (25°C) | DMSO 80 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Toni L Ripley, et al. Candesartan in heart failure
| Related Angiotensin Receptor Products |
|---|
| Azilsartan medoxomil
Azilsartan Medoxomil is an effective angiotensin II Type 1 (AT1) receptor antagonist that inhibits RAAS more than 10,000 times more selectively than AT2, and is used to study hypertension. |
| Azilsartan
Azilsartan (TAK-536) is an angiotensin II type 1 (AT1) receptor antagonist with IC50 of 2.6 nM. Azilsartan induces ROS formation and apoptosis in HepG2 cells. Azilsartan shows neuroprotective and anticancer activity. |
| PD 123319 ditrifluoroacetate
PD 123319 ditrifluoroacetate is a potent, selective, non-peptide angiotensin AT2 receptor antagonist. |
| Losartan potassium
Losartan potassium is a selective non-peptide angiotensin AT1 receptor antagonist. |
| Eprosartan Mesylate
Eprosartan is a nonpeptide angiotensin II receptor antagonist, [3H]-eprosartan binds to the AT1 receptor with KD of 0.83 nM in rat vascular smooth muscle cells. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
